Literature DB >> 33351903

Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study.

Stéphanie Larramendy1, Aurélie Gaultier1,2, Jean-Pascal Fournier1, Jocelyne Caillon3, Leïla Moret4,5, François Beaudeau6.   

Abstract

OBJECTIVES: The prevalence of ESBL-producing Escherichia coli (ESBL-E. coli) in community-acquired urinary tract infections (UTI) has been increasing worldwide since 2000, but with large geographical variations. The aim of this study was to determine whether the ESBL-E. coli rate in urine samples from individuals with community-acquired UTI was associated with the local socio-economic, environmental, agricultural and healthcare characteristics.
METHODS: This was a cross-sectional study in western France using data on antibiotic susceptibility of E. coli isolated from urine samples of individuals with community-acquired UTI analysed in non-hospital laboratories from 2015 to 2017. The ESBL-E. coli rate was calculated for each laboratory. Data on socio-economic characteristics, human antibiotic consumption, hospital bed density, animal farming density and percentage of agricultural land and surface water were retrieved at the municipality level and aggregated by study area. Their association with ESBL-E. coli prevalence was quantified using multivariate linear regression models with a backward selection.
RESULTS: From 358 291 E. coli isolates from urine samples tested in 92 laboratories, the mean ESBL-E. coli prevalence for the study period was 3.30%. In an adjusted model, the ESBL-E. coli rate was significantly (P < 0.05) and positively associated with the local percentage of people >65 years old, third-generation cephalosporin use (DDD/1000 inhabitants), number of hospital beds/km2, poultry density, pig density and percentage of agricultural land. Lower deprivation was associated with a higher ESBL-E. coli rate.
CONCLUSIONS: Several anthropogenic factors (primary care, hospitals and animal farming) are associated with the local ESBL-E. coli rate in community-acquired UTI. These results could contribute to improve risk management, including identification of at-risk patient groups.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33351903     DOI: 10.1093/jac/dkaa514

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Pattern of Antibiotic Use among Hospitalized Patients according to WHO Access, Watch, Reserve (AWaRe) Classification: Findings from a Point Prevalence Survey in Bangladesh.

Authors:  Md Mahbubur Rashid; Zubair Akhtar; Sukanta Chowdhury; Md Ariful Islam; Shahana Parveen; Probir Kumar Ghosh; Aninda Rahman; Zobaidul Haque Khan; Khaleda Islam; Nitish Debnath; Mahmudur Rahman; Fahmida Chowdhury
Journal:  Antibiotics (Basel)       Date:  2022-06-16

2.  Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries.

Authors:  Ines Pauwels; Ann Versporten; Nico Drapier; Erika Vlieghe; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2021-05-12       Impact factor: 5.790

3.  Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase-Producing Escherichia coli Urinary Tract Infections in France.

Authors:  Adeline Paumier; Antoine Asquier-Khati; Sonia Thibaut; Thomas Coeffic; Olivier Lemenand; Stéphanie Larramendy; Brice Leclère; Jocelyne Caillon; David Boutoille; Gabriel Birgand
Journal:  JAMA Netw Open       Date:  2022-09-01

4.  Sociodemographic Inequalities in Urinary Tract Infection in 2 Large California Health Systems.

Authors:  Joan A Casey; Kara E Rudolph; Sarah C Robinson; Katia Bruxvoort; Eva Raphael; Vennis Hong; Alice Pressman; Rachel Morello-Frosch; Rong X Wei; Sara Y Tartof
Journal:  Open Forum Infect Dis       Date:  2021-05-26       Impact factor: 3.835

5.  Oral Antibiotics in Clinical Development for Community-Acquired Urinary Tract Infections.

Authors:  Balaji Veeraraghavan; Yamuna Devi Bakthavatchalam; Rani Diana Sahni
Journal:  Infect Dis Ther       Date:  2021-08-06

6.  Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in France.

Authors:  Eric Farfour; Laurent Dortet; Thomas Guillard; Nicolas Chatelain; Agathe Poisson; Assaf Mizrahi; Damien Fournier; Rémy A Bonnin; Nicolas Degand; Philippe Morand; Frédéric Janvier; Vincent Fihman; Stéphane Corvec; Lauranne Broutin; Cécile Le Brun; Nicolas Yin; Geneviève Héry-Arnaud; Antoine Grillon; Emmanuelle Bille; Hélène Jean-Pierre; Marlène Amara; Francoise Jaureguy; Christophe Isnard; Vincent Cattoir; Tristan Diedrich; Emilie Flevin; Audrey Merens; Hervé Jacquier; Marc Vasse
Journal:  Pathogens       Date:  2022-03-15

7.  High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study.

Authors:  Peiyao Jia; Ying Zhu; Xue Li; Timothy Kudinha; Yang Yang; Ge Zhang; Jingjia Zhang; Yingchun Xu; Qiwen Yang
Journal:  Front Microbiol       Date:  2021-07-07       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.